IPO Date | September 30, 2025 to October 3, 2025 |
Listing Date | October 8, 2025 |
Face Value | ₹ 10 / Share |
Price Band | ₹ 59 to ₹ 63 / Share |
Lot Size | 2000 Shares |
Total Issue Size | 54,00,000 shares (Aggregating up to ₹34.02 Cr) |
Fresh Issue | |
Offer for Sale | |
Employee Discount | |
Issue Type | Bookbuilding IPO |
Listing At | NSE SME |
Share holding pre issue | 1,49,52,550 shares |
Share holding post issue | 2,03,52,550 shares |
Market Maker portion |
Sheel Biotech Limited IPO opens on September 30, 2025, and closes on October 3, 2025.
IPO Open Date | September 30, 2025 |
IPO Close Date | October 3, 2025 |
Basis of Allotment | October 6, 2025 |
Initiation of Refunds | October 7, 2025 |
Credit of Shares to Demat | October 7, 2025 |
Listing Date | October 8, 2025 |
Cut-off time for UPI mandate confirmation | October 3, 2025 |
Investors can bid for a minimum of 4,000 shares and in multiples of 2,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 2 | 4,000 | Rs.252,000 |
Retail (Max) | 2 | 4,000 | Rs.252,000 |
S-HNI (Min) | 3 | 6,000 | Rs.378,000 |
S-HNI (Max) | 7 | 14,000 | Rs.882,000 |
B-HNI (Min) | 8 | 16,000 | Rs.1,008,000 |
HNI (Min) |
Share Holding Pre Issue | 96.99% |
Share Holding Post Issue | 71.26% |
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
Anchor Investor Shares Offered | |
|
Market Maker Shares Offered | |
|
Other Shares Offered | |
|
QIB Shares Offered | Not more than 50% |
|
NII (HNI) Shares Offered | Not less than 15% |
|
bNII > ₹10L | |
|
sNII < ₹10L | |
|
Retail Shares Offered | Not less than 35.00% |
|
Employee Shares Offered | |
|
Total Shares Offered | |
Bid Date | |
Shares Offered | |
Anchor Portion Size (In Cr.) | |
Anchor lock-in period end date for 50% shares (30 Days) | |
Anchor lock-in period end date for remaining shares (90 Days) |
Incorporated in November 1991, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.
The company grows and supplies various plants for field crops, fruits, vegetables, and ornamentals through tissue culture and organic farming.
The company manufactures and maintains greenhouses, provides farmer services, and offers training through FPOs.
They also deliver landscaping services to the government and private sectors.
The company holds ISO 9001:2015, 14001:2015, and 45001:2018 certifications, reflecting its commitment to quality, environmental responsibility, and safety.
The company's Research and Development laboratory is recognized by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST) of the Government of India.
Sheel Biotech offers a diverse range of services and products, including:
As of September 30, 2024, the Company has 160 permanent employees on its payroll.
Competitive Strength:
The market capitalization of Sheel Biotech IPO is ₹128.22 Cr.
KPI | Values |
---|---|
ROE | 13.59% |
ROCE | 16.34% |
Debt/Equity | 0.32 |
RoNW | 13.59% |
P/BV | 1.26 |
PAT Margin (%) |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 7.03 | 1.43 |
P/E (x) | 8.96 | 44.07 |
Sheel Biotech Ltd. 8 Balaji Estates , 2nd Floor, Block-C, Guru Ravidas Marg Kalkaji South Delhi, New Delhi, 110019 Phone: +91 88511 - 8980 Email: [email protected] Website: http://www.sheelbiotech.com/ |
Skyline Financial Services Pvt.Ltd. Phone: 02228511022 Email: [email protected] Website: https://www.skylinerta.com/ipo.php |